First-line nivolumab in stage IV or recurrent non-small-cell lung cancer

D.P. Carbone, M. Reck, L. Paz-Ares, B. Creelan, L. Horn, M. Steins, E. Felip, M.M. Van Den Heuvel, T.-E. Ciuleanu, F. Badin, N. Ready, T.J.N. Hiltermann, S. Nair, R. Juergens, S. Peters, E. Minenza, J.M. Wrangle, D. Rodriguez-Abreu, H. Borghaei, Jr. Blumenschein G.R.L.C. Villaruz, L. Havel, J. Krejci, J. Corral Jaime, H. Chang, W.J. Geese, P. Bhagavatheeswaran, A.C. Chen, M.A. Socinski, Lucio Crinò

Research output: Contribution to journalArticlepeer-review

Original languageItalian
Pages (from-to)2415-2426
Number of pages12
JournalNew England Journal of Medicine
Issue number25
Publication statusPublished - 2017

Cite this